|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 31/337 | (2006.01) | ||
| A61K 31/513 | (2006.01) | ||
| A61K 33/24 | (2019.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61P 1/00 | (2006.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3708583 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19151147.6 |
| Date of filing the European patent application | 2014-07-31 | |
| (97) | Date of publication of the European application | 2020-09-16 |
| (45) | Date of publication and mention of the grant of the patent | 2022-03-02 |
| (46) | Date of publication of the claims translation | 2022-04-11 |
| (30) | Number | Date | Country code |
| 201361861198 P | 2013-08-01 | US | |
| 201361901732 P | 2013-11-08 | US | |
| 201461933632 P | 2014-01-30 | US |
| (72) |
HARDING, Thomas , US
PIERCE, Kristen , US
PATIL, Namrata , US
BRENNAN, Thomas , US
HAMBLETON, Julie , US
|
| (73) |
Five Prime Therapeutics, Inc. ,
111 Oyster Point Boulevard, South San Francisco, CA 94080,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Afukozilinti anti-FGFR2IIIb antikūnai |
| AFUCOSYLATED ANTI-FGFR2IIIB ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2025-06-19 | 12 | 289.00 EUR |
| 2026-07-31 |